$1.79 Billion is the total value of Cormorant Asset Management, LP's 64 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 44.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $415,247,100 | +281572.4% | 8,142,100 | +18.1% | 23.26% | +139.6% | |
| AMAM | Buy | AMBRX BIOPHARMA INCsponsored ads | $158,281,911 | +208660.1% | 9,616,155 | +13.1% | 8.87% | +77.6% |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $119,341,000 | +132935.7% | 1,310,000 | -3.7% | 6.68% | +13.2% |
| BMEA | BIOMEA FUSION INC | $78,380,646 | +70683.5% | 3,570,872 | 0.0% | 4.39% | -39.8% | |
| BBIO | Sell | BRIDGEBIO PHARMA INC | $71,709,879 | +94802.0% | 4,169,179 | -8.5% | 4.02% | -19.3% |
| Buy | ARCELLX INC | $63,240,000 | +128186.3% | 2,000,000 | +25.0% | 3.54% | +9.1% | |
| Buy | IMMUNEERING CORP | $42,632,251 | +183897.6% | 4,204,364 | +76.2% | 2.39% | +56.5% | |
| CBAY | Buy | CYMABAY THERAPEUTICS INC | $41,610,000 | +375204.4% | 3,800,000 | +198.9% | 2.33% | +219.3% |
| PTGX | Sell | PROTAGONIST THERAPEUTICS INC | $41,430,000 | +105859.1% | 1,500,000 | -11.8% | 2.32% | -9.9% |
| ENLIVEN THERAPEUTICS INC | $39,516,475 | +93097.0% | 1,936,133 | 0.0% | 2.21% | -20.7% | ||
| PCVX | Buy | VAXCYTE INC | $33,210,100 | +322109.2% | 665,000 | +141.8% | 1.86% | +173.9% |
| DSGN | DESIGN THERAPEUTICS INC | $32,445,000 | +109083.6% | 5,150,000 | 0.0% | 1.82% | -7.2% | |
| ZNTL | New | ZENTALIS PHARMACEUTICALS INC | $30,889,950 | – | 1,095,000 | +100.0% | 1.73% | – |
| ERASCA INC | $29,844,559 | +91594.0% | 10,813,246 | 0.0% | 1.67% | -22.0% | ||
| RNA | AVIDITY BIOSCIENCES INC | $28,968,355 | +72147.5% | 2,612,115 | 0.0% | 1.62% | -38.5% | |
| CABA | Buy | CABALETTA BIO INC | $28,682,650 | +190280.0% | 2,221,739 | +22.0% | 1.61% | +62.0% |
| EYPT | Buy | EYEPOINT PHARMACEUTICALS INC | $27,840,000 | +4205338.1% | 3,200,000 | +1321.8% | 1.56% | +3445.5% |
| OLMA | OLEMA PHARMACEUTICALS INC | $27,830,460 | +260119.4% | 3,082,000 | 0.0% | 1.56% | +121.4% | |
| AVTE | AEROVATE THERAPEUTICS INC | $26,783,086 | +84928.4% | 1,561,696 | 0.0% | 1.50% | -27.7% | |
| TARS | TARSUS PHARMACEUTICALS INC | $25,685,096 | +143657.2% | 1,421,422 | 0.0% | 1.44% | +22.3% | |
| ETNB | Sell | 89BIO INC | $25,582,500 | +59890.9% | 1,350,000 | -51.8% | 1.43% | -49.0% |
| AXSM | Buy | AXSOME THERAPEUTICS INC | $24,432,400 | +131938.5% | 340,000 | +13.3% | 1.37% | +12.3% |
| STRUCTURE THERAPEUTICS INCsponsored ads | $23,959,826 | +174636.2% | 576,373 | 0.0% | 1.34% | +48.6% | ||
| EWTX | EDGEWISE THERAPEUTICS INC | $22,838,374 | +116090.3% | 2,946,887 | 0.0% | 1.28% | -1.2% | |
| VRDN | VIRIDIAN THERAPEUTICS INC | $20,221,500 | +93414.2% | 850,000 | 0.0% | 1.13% | -20.4% | |
| KRTX | KARUNA THERAPEUTICS INC | $17,348,000 | +119286.1% | 80,000 | 0.0% | 0.97% | +1.6% | |
| LBPH | LONGBOARD PHARMACEUTICALS IN | $17,272,055 | +182944.2% | 2,353,141 | 0.0% | 0.97% | +55.9% | |
| RCKT | ROCKET PHARMACEUTICALS INC | $17,258,089 | +115897.4% | 868,550 | 0.0% | 0.97% | -1.3% | |
| AXNX | AXONICS INC | $16,263,453 | +92405.8% | 322,240 | 0.0% | 0.91% | -21.3% | |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $14,887,600 | +98096.7% | 130,000 | +18.2% | 0.83% | -16.4% |
| PHVS | Buy | PHARVARIS N V | $14,740,516 | +224022.2% | 973,614 | +19.2% | 0.83% | +90.8% |
| IDYA | Buy | IDEAYA BIOSCIENCES INC | $14,100,000 | +293283.3% | 600,000 | +71.4% | 0.79% | +149.2% |
| BBIO | New | BRIDGEBIO PHARMA INCput | $13,945,760 | – | 810,800 | +100.0% | 0.78% | – |
| COGT | Buy | COGENT BIOSCIENCES INC | $11,840,000 | +156658.9% | 1,000,000 | +42.9% | 0.66% | +33.4% |
| ISEE | New | IVERIC BIO INCcall | $11,802,000 | – | 300,000 | +100.0% | 0.66% | – |
| STOK | STOKE THERAPEUTICS INC | $11,563,388 | +127517.1% | 1,087,807 | 0.0% | 0.65% | +8.5% | |
| PRAX | New | PRAXIS PRECISION MEDICINES I | $10,925,000 | – | 9,500,000 | +100.0% | 0.61% | – |
| IMVT | New | IMMUNOVANT INC | $10,433,500 | – | 550,000 | +100.0% | 0.58% | – |
| New | DISC MEDICINE INC | $9,990,000 | – | 225,000 | +100.0% | 0.56% | – | |
| RYTM | New | RHYTHM PHARMACEUTICALS INC | $9,894,000 | – | 600,000 | +100.0% | 0.55% | – |
| LIANBIOsponsored ads | $9,690,000 | +116226.5% | 4,250,000 | 0.0% | 0.54% | -1.1% | ||
| MORF | Sell | MORPHIC HLDG INC | $8,599,500 | +70197.6% | 150,000 | -53.8% | 0.48% | -40.2% |
| ASTRIA THERAPEUTICS INC | $8,330,000 | +62531.6% | 1,000,000 | 0.0% | 0.47% | -46.7% | ||
| ARQT | New | ARCUTIS BIOTHERAPEUTICS INC | $7,624,000 | – | 800,000 | +100.0% | 0.43% | – |
| GHRS | GH RESEARCH PLCordinary shares | $7,036,455 | +148411.1% | 593,043 | 0.0% | 0.39% | +26.3% | |
| VERV | VERVE THERAPEUTICS INC | $6,562,500 | +129927.7% | 350,000 | 0.0% | 0.37% | +10.8% | |
| RAPT | Sell | RAPT THERAPEUTICS INC | $6,077,500 | +50851.5% | 325,000 | -50.0% | 0.34% | -56.7% |
| VIGIL NEUROSCIENCE INC | $5,797,788 | +95921.7% | 616,786 | 0.0% | 0.32% | -18.3% | ||
| AVIR | ATEA PHARMACEUTICALS INC | $5,786,457 | +111543.0% | 1,547,181 | 0.0% | 0.32% | -5.0% | |
| AKRO | New | AKERO THERAPEUTICS INC | $5,369,350 | – | 115,000 | +100.0% | 0.30% | – |
| ALXO | ALX ONCOLOGY HLDGS INC | $4,596,713 | +166026.2% | 612,079 | 0.0% | 0.26% | +41.2% | |
| APLS | New | APELLIS PHARMACEUTICALS INCcall | $3,552,900 | – | 39,000 | +100.0% | 0.20% | – |
| BCAB | BIOATLA INC | $3,543,345 | +111854.0% | 1,181,115 | 0.0% | 0.20% | -4.8% | |
| CNTA | CENTESSA PHARMACEUTICALS PLCsponsored ads | $3,476,304 | +160691.1% | 561,600 | 0.0% | 0.20% | +37.3% | |
| New | LEAP THERAPEUTICS INC | $3,358,634 | – | 1,073,046 | +100.0% | 0.19% | – | |
| OCUL | New | OCULAR THERAPEUTIX INC | $3,328,200 | – | 645,000 | +100.0% | 0.19% | – |
| GREENLIGHT BIOSCIENCS HLDS P | $2,739,139 | +68843.8% | 9,188,659 | 0.0% | 0.15% | -41.6% | ||
| GLTO | GALECTO INC | $2,571,000 | +126550.2% | 1,020,238 | 0.0% | 0.14% | +7.5% | |
| BIOHAVEN LTD | $1,960,555 | +174949.6% | 81,963 | 0.0% | 0.11% | +48.6% | ||
| AUTL | AUTOLUS THERAPEUTICS PLCspon ads | $933,357 | +129173.8% | 392,167 | 0.0% | 0.05% | +8.3% | |
| GRPH | GRAPHITE BIO INC | $518,822 | +105998.6% | 199,547 | 0.0% | 0.03% | -9.4% | |
| HARP | HARPOON THERAPEUTICS INC | $383,826 | +95379.1% | 540,600 | 0.0% | 0.02% | -15.4% | |
| BCEL | ATRECA INC | $312,676 | +85800.0% | 319,057 | 0.0% | 0.02% | -25.0% | |
| ORCHARD THERAPEUTICS PLCspon ads new | $133,709 | +96790.6% | 25,664 | 0.0% | 0.01% | -22.2% | ||
| CMMB | Exit | CHEMOMAB THERAPEUTICS LTDsponsored ads | $0 | – | -288,169 | -100.0% | -0.03% | – |
| LPTX | Exit | LEAP THERAPEUTICS INC | $0 | – | -1,481,511 | -100.0% | -0.03% | – |
| Exit | PYXIS ONCOLOGY INC | $0 | – | -272,537 | -100.0% | -0.07% | – | |
| XFOR | Exit | X4 PHARMACEUTICALS INC | $0 | – | -1,628,980 | -100.0% | -0.09% | – |
| TALS | Exit | TALARIS THERAPEUTICS INC | $0 | – | -900,649 | -100.0% | -0.11% | – |
| ELDN | Exit | ELEDON PHARMACEUTICALS INC | $0 | – | -1,217,882 | -100.0% | -0.19% | – |
| PSTX | Exit | POSEIDA THERAPEUTICS INC | $0 | – | -1,000,000 | -100.0% | -0.20% | – |
| FULC | Exit | FULCRUM THERAPEUTICS INC | $0 | – | -1,081,490 | -100.0% | -0.20% | – |
| ELEV | Exit | ELEVATION ONCOLOGY INC | $0 | – | -1,952,032 | -100.0% | -0.24% | – |
| Exit | ICOSAVAX INC | $0 | – | -643,825 | -100.0% | -0.25% | – | |
| ANNX | Exit | ANNEXON INC | $0 | – | -1,250,000 | -100.0% | -0.32% | – |
| Exit | PRIME MEDICINE INC | $0 | – | -734,350 | -100.0% | -0.60% | – | |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -296,000 | -100.0% | -0.69% | – |
| Exit | TANGO THERAPEUTICS INC | $0 | – | -4,116,949 | -100.0% | -1.07% | – | |
| VKTX | Exit | VIKING THERAPEUTICS INC | $0 | – | -1,050,000 | -100.0% | -1.15% | – |
| VECT | Exit | VECTIVBIO HLDG AG | $0 | – | -2,536,617 | -100.0% | -1.42% | – |
| GLUE | Exit | MONTE ROSA THERAPEUTICS INC | $0 | – | -2,893,717 | -100.0% | -1.48% | – |
| RAIN | Exit | RAIN ONCOLOGY INC | $0 | – | -2,978,660 | -100.0% | -1.71% | – |
| PLRX | Exit | PLIANT THERAPEUTICS INC | $0 | – | -1,444,000 | -100.0% | -2.53% | – |
| RXDX | Exit | PROMETHEUS BIOSCIENCES INC | $0 | – | -1,655,000 | -100.0% | -11.70% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| QUOTIENT LTD | 30 | Q3 2021 | 4.3% |
| ASCENDIS PHARMA A/S | 30 | Q4 2022 | 4.8% |
| MINERVA NEUROSCIENCES INC | 29 | Q3 2021 | 4.4% |
| ACCELERON PHARMA INC | 28 | Q2 2021 | 3.4% |
| OMEROS CORP | 27 | Q3 2021 | 6.5% |
| MIRATI THERAPEUTICS INC | 25 | Q4 2022 | 7.6% |
| BLUEPRINT MEDICINES CORP | 25 | Q3 2021 | 3.6% |
| APELLIS PHARMACEUTICALS INC | 24 | Q3 2023 | 8.6% |
| NEUROCRINE BIOSCIENCES INC | 24 | Q1 2020 | 4.6% |
| ROCKET PHARMACEUTICALS, INC | 23 | Q3 2023 | 2.4% |
View Cormorant Asset Management, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Ambrx Biopharma Inc. | March 13, 2023 | 42,771,365 | - |
| Altimmune, Inc. | February 14, 2023 | 2,600,000 | - |
| Arcellx, Inc. | February 14, 2023 | 2,075,000 | - |
| BioAtla, Inc. | February 14, 2023 | 2,499,250 | - |
| Eledon Pharmaceuticals, Inc. | February 14, 2023 | 1,391,663 | - |
| GreenLight Biosciences Holdings, PBC | February 14, 2023 | 4,751,020 | - |
| Prometheus Biosciences, Inc. | February 14, 2023 | 700,000 | - |
| Tango Therapeutics, Inc. | February 14, 2023 | 1,000,000 | - |
| VectivBio Holding AG | February 14, 2023 | 1,515,087 | - |
| Viridian Therapeutics, Inc.\DE | February 14, 2023 | 1,100,000 | - |
View Cormorant Asset Management, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-22 |
| SC 13G/A | 2024-04-15 |
| 4 | 2024-04-03 |
| SC 13G | 2024-03-21 |
| 4 | 2024-03-18 |
| SC 13G/A | 2024-03-18 |
| 4 | 2024-03-11 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Cormorant Asset Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.